VMPLNew Delhi [India], June 23: In one of oncology’s most anatomically complex regions, the difference between an accurate treatment plan and an imprecise one can be measured in millimetres, and felt ...
A multi-disciplinary task force convened by the American Society for Radiation Oncology has issued new guidelines for radiation therapy for HPV-associated oropharyngeal squamous cell carcinoma (OPSCC) ...
Randomized Phase II Study of Concurrent Versus Sequential Pembrolizumab in Combination With Chemoradiation in Locally Advanced Head and Neck Cancer Newly diagnosed patients with cT2-4N0-2M0 HNC were ...
Cancers occurring in the mouth, nose, and throat are on the rise in the U.S., especially in younger people. About 60,000 new cases are diagnosed every year, with one in five cases occurring in people ...
Photobiomodulation therapy significantly reduced severe oral mucositis and PEG tube placements in head and neck cancer patients undergoing radiotherapy. Patient-reported outcomes showed less mouth and ...
Head and neck cancer symptoms vary by tumor location, often presenting as a neck lump or voice changes. Smoking and HPV are major risk factors; cessation and vaccination are crucial preventive ...
In more recent decades, HPV has been shown as a risk factor for developing head and neck cancer. Head and neck cancer covers everything from throat, tongue, and tonsil cancer to laryngeal, mouth, and ...
A five-minute oral cancer screening can detect early warning signs, enabling timely treatment, improving survival, and ...
Ravindra Uppaluri, MD, PhD, lead investigator of the phase 3 KEYNOTE-689 trial (NCT03765918), highlights the potential of pembrolizumab (Keytruda; Merck) to improve outcomes following head and neck ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results